VahatiCor - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeVahatiCor
VahatiCor logo

VahatiCor

0 followers

About VahatiCor

VahatiCor specializes in developing innovative medical solutions for coronary microvascular dysfunction. Their flagship product, the A-FLUX Reducer System, aims to alleviate chronic symptoms such as chest pain and shortness of breath in patients. It is important to note that this system is currently an experimental treatment and is not approved for ischemic heart disease in the U.S.

Recent News

Recent Deals

Key Team Members

Kevin Van Bladel

CTO

Janie Mandrusov

VP, Clinical Affairs

Michael Mandel

Head of Corporate Development

Mark Niggli

CCO

Marwan Berrada

Founder and Chairman

Key Facts

HQ Location

Santa Clara, United States

Founded

2021

Employees

1 - 10

Status

Private

Website

https://vahaticor.com